Archives
EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Stable Cap 1 Red Fluo...
EZ Cap™ mCherry mRNA (5mCTP, ψUTP): Stable Cap 1 Red Fluorescent Reporter
Executive Summary: EZ Cap™ mCherry mRNA (5mCTP, ψUTP) is a synthetic messenger RNA of 996 nucleotides, encoding monomeric mCherry—a red fluorescent protein derived from Discosoma's DsRed. This mRNA features a Cap 1 structure, enzymatically added for improved translation efficiency and mammalian mimicry. Modified nucleotides (5mCTP and ψUTP) confer innate immune evasion and superior stability. The product is supplied at ~1 mg/mL in 1 mM sodium citrate, pH 6.4, and is intended as a high-fidelity molecular marker for cell localization and reporter assays (APExBIO). Cap 1–modified mRNAs like this are compatible with lipid nanoparticle delivery and have been benchmarked in advanced cell biology and gene editing workflows (Guri-Lamce et al. 2024).
Biological Rationale
Messenger RNA (mRNA) encoding fluorescent proteins enables direct, transient expression for cell imaging, localization, and tracking experiments. mCherry, a 28.8 kDa monomeric red fluorescent protein, emits at 610 nm and is derived from DsRed of Discosoma species (FPbase). Cap 1 capping at the mRNA 5' end is essential for maximal ribosome recruitment and translation efficiency in mammalian systems (see related). Modified nucleotides, such as 5-methylcytidine (5mCTP) and pseudouridine (ψUTP), are incorporated to suppress innate immune activation and increase mRNA stability (Guri-Lamce et al. 2024). Polyadenylation (poly(A) tail) further enhances translation initiation and mRNA persistence.
Mechanism of Action of EZ Cap™ mCherry mRNA (5mCTP, ψUTP)
- Cap 1 Structure: The mRNA is capped enzymatically with Vaccinia virus Capping Enzyme, GTP, S-adenosylmethionine, and 2´-O-Methyltransferase, forming a Cap 1 structure (m7GpppNm). This cap mimics native mammalian mRNAs, enhancing translation and evading innate immune sensors (details).
- Modified Nucleotides: Incorporation of 5mCTP and ψUTP decreases activation of RNA sensors such as TLR7/8 and RIG-I (Guri-Lamce et al. 2024), reducing cytokine response and increasing mRNA half-life.
- Poly(A) Tail: A defined polyadenylated tail supports efficient translation initiation and mRNA stabilization in cytosolic environments.
- Red Fluorescence: mCherry’s emission maximum is 610 nm, with excitation at 587 nm, enabling unambiguous spectral separation from green and cyan fluorophores (FPbase).
Evidence & Benchmarks
- Cap 1–modified mRNAs exhibit significantly higher translational efficiency and stability in mammalian cells compared to uncapped or Cap 0 mRNAs (Guri-Lamce et al. 2024).
- Inclusion of 5mCTP and ψUTP suppresses RNA-mediated innate immune activation, as measured by reduced IFN-β induction (Guri-Lamce et al. 2024).
- mCherry mRNA (~996 nt) enables robust fluorescent protein expression within 4–24 hours post-transfection using standard lipid delivery reagents (APExBIO).
- Lipid nanoparticles effectively encapsulate and deliver Cap 1–modified mRNAs for high-efficiency gene expression in vitro (Guri-Lamce et al. 2024).
- Poly(A)-tailed, modified mRNAs remain stable at –40°C or below for at least 12 months without detectable degradation (APExBIO).
Applications, Limits & Misconceptions
- Use as a fluorescent reporter gene for quantifying transfection efficiency.
- Cellular component localization via direct mCherry visualization.
- Benchmarking mRNA delivery technologies, including lipid nanoparticles and electroporation (see more; this article provides detailed stability metrics and workflow integration strategies).
- Tracking cell fate in live imaging—mCherry’s emission allows multiplexing with GFP/YFP markers.
Common Pitfalls or Misconceptions
- This product is not suitable for in vivo therapeutic use; it is for research only.
- mCherry mRNA does not permanently integrate into the genome—expression is transient (typically 1–4 days).
- Storage above –40°C rapidly degrades mRNA stability and function.
- Using non-optimized transfection reagents can significantly reduce fluorescence signal.
- Cap 1 and modified nucleotides reduce, but do not fully eliminate, innate immune recognition in all cell types (see clarification—this article updates immune evasion boundaries).
Workflow Integration & Parameters
- Supplied at ~1 mg/mL in 1 mM sodium citrate, pH 6.4; dilute immediately before use to avoid freeze-thaw cycles.
- Optimal storage is at or below –40°C; aliquot to prevent repeated thawing (R1017 kit protocols).
- Transfect with lipid-based reagents (e.g., Lipofectamine MessengerMAX) or electroporation; typical input is 50–200 ng/well (24-well plate) (see troubleshooting guide—this article focuses on signal fidelity improvements).
- Observe red fluorescence at 24 h post-transfection; excitation/emission maxima are 587/610 nm.
- Combine with blue/green fluorophores for multiplexed imaging.
Conclusion & Outlook
EZ Cap™ mCherry mRNA (5mCTP, ψUTP) from APExBIO offers a high-fidelity, stable, and immune-evasive solution for red fluorescent protein expression in cell biology research. Cap 1 capping, modified nucleotides, and poly(A) tailing collectively enhance mRNA performance, enabling precise molecular tracking and localization studies. As mRNA-based tools advance, such constructs will underpin next-generation workflows in live-cell imaging, synthetic biology, and functional genomics (Guri-Lamce et al. 2024).